
Pawan Gupta
· ProfessorVerifiedUniversity of California, Los Angeles · Nuclear Medicine & Theranostics
Active 1975–2025
Research topics
- Computer Science
- Oncology
- Cell biology
- Medicine
- Urology
- Internal medicine
- Biology
- Biochemistry
- Surgery
- Cancer research
- Nuclear medicine
- Computational biology
- Genetics
Selected publications
Beyond the Prostate: Incidental Detection of Male Breast Carcinoma on [ <sup>18</sup> F]DCFPyl
Journal of Nuclear Medicine · 2025-12-18
articleOpen accessProstate-specific membrane antigen (PSMA) is consistently expressed in tumor neovasculature but variably in tumor cells, with prior reports demonstrating PSMA uptake in invasive ductal carcinoma in men ([1][1]). This case reinforces the value of PSMA in characterizing breast cancer in men,
Heart Disease Prediction Using Knowledge Graphs
2025-04-09
article1st authorCorrespondingThis work demonstrates how to improve the prediction of heart illness by integrating ML models with knowledge graphs. By leveraging knowledge graphs to represent the relational structure among clinical and demographic features, the proposed framework improves the interpretability and predictive accuracy of traditional machine learning techniques. A GNN is employed to process the enriched feature set, capturing complex interdependencies and patterns in the data. The dataset, consisting of 1,025 patient records, was preprocessed and used to train and validate multiple models, including Logistic Regression, Decision Tree, Random Forest, and GNN. Results demonstrate that the Random Forest and Decision Tree outperforms traditional models, achieving a test accuracy of 98.5% while maintaining high precision and recall. Our Research highlights the potential of combining knowledge graphs with modern ML methods to address complex challenges in medicine, opening up the way to more reliable and interpretable diagnostic tools.
Orchestrating autoimmune diseases through nuclear receptors and orphan GPCRs
2025-07-28
book-chapterSenior authorOsteoarthritis and Cartilage · 2025-04-01
article1st authorCorrespondingElsevier eBooks · 2025-01-01 · 8 citations
book-chapterSenior authorStructure-Based Drug Design for Tuberculosis
Apple Academic Press eBooks · 2025-10-15
book-chapterSenior authorStructure-based drug design (SBDD) is one of the advanced techniques of computeraided drug design used to expedite the drug discovery process. Tuberculosis (TB) is one of the therapeutic areas where the discovery of novel therapeutics—and the use of existing therapeutics—is still challenging due to microbial drug resistance (MDR). SBDD techniques are being utilized to exploit various therapeutically viable anti-TB targets to obtain novel scaffolds, such as RNA polymerase, enoyl-acyl protein reductase, DprEl, DprE2, MmpL3, MmpL7, QcrB, topoisomerase II complex (DNA gyrase), EmbC [arabinogalactan (AG) and lipoarabinomannan (LAM)], EthR2, F-ATP synthase, ketomycolic acid, and methoxy mycolic acid synthesis. The inspiring journey of the life-saving anti-TB drug Bedaquiline (TMC207) against MDR TB began with the screening of a 70,000-compound library against the F-ATP synthase of a non-pathogenic TB strain, followed by subsequent SBDD efforts. Moreover, the nitroimidazole derivatives Delamanid and Pretomanid were discovered through scaffold modification and high-throughput screening. The benzothiazinone derivative Macozinone was discovered through a lead optimization campaign targeting DprEl inhibitors. Several successful SBDD studies have been reported in recent years, facilitating the discovery of novel anti-TB agents. In this chapter, SBDD approaches are discussed in connection with the discovery and optimization of anti-TB drugs.
Organoid: Biomedical application, biobanking, and pathways to translation
Heliyon · 2025-02-26 · 10 citations
articleOpen accessOrganoids are tiny stem cell-derived 3D in vitro cell culture systems mimicking the structural and functional aspects of the tissues in the human body and provide a means to study complex bio-physiological processes in normal and disease states (disease modeling) and also for therapeutic screening and clinical trials. Scientists have now developed protocols to maintain and use organoids from diverse human tissues, including the gut, liver, brain, and pancreas, and they have the potential to reduce or remove the dependency on animal models and have research utility and translational potential. One major advantage is that they can be generated from patients with specific genetic diseases, thereby providing options for exploring personalized medicine and rare diseases lacking robust animal models. Recent advances in multi-omics technologies, imaging technologies, biomaterial chemistry, bioengineering, microfluidics, and stem cell research have revolutionized organoid bioengineering, opening the opportunity for mass production, biobanking, and commercialization.
Journal of Human Values · 2025-08-14
articleSenior authorIt is now increasingly acknowledged that modern lifestyle can no longer be sustained on the planet. The success of modernity has landed humanity in the ‘development paradox’, where human progress threatens human survival. However, the predominant discussion on sustainability primarily centres around elongating the modern lifestyle, based on Western values of materialism, individualism and consumerism. It is also evident that the lingering problems of our times cannot be resolved within the prevalent worldview heavily loaded with materialism. Therefore, there is a need for a paradigm shift. In this regard, India can provide answers to develop an alternative framework of sustainability. This study attempts to situate two important philosophical concepts, namely yajña and saha-astitva , amidst the contemporary discussions on sustainability. This study also draws upon important learnings from traditional Indian villages. To study the functioning of traditional villages (or jajmāni system) from the perspective of sustainability is a novel attempt.
When PSMA lights up the thyroid: an incidental discovery of a second primary on [68Ga]Ga-PSMA-11
European Journal of Nuclear Medicine and Molecular Imaging · 2025-06-05
articleOpen accessSenior authorComplications of Diabetics in SARS-COVID patients
International Journal of Medical Pharmaceutical and Health Sciences (IJMPHS). · 2024-03-25
article1st authorCorresponding
Recent grants
NIH · $267k · 1989
NIH · $178k · 1987
Frequent coauthors
- 41 shared
Ella Bhagyaraj
Institute of Microbial Technology
- 34 shared
Nancy Ahuja
Institute of Microbial Technology
- 32 shared
Sahil Mahajan
- 31 shared
Drishti Tiwari
Industrial Research Institute
- 30 shared
Martin Allen-Auerbach
Molecular Theranostics (United States)
- 28 shared
Ravikanth Nanduri
The University of Texas Southwestern Medical Center
- 28 shared
Sumit Kumar
Institute of Microbial Technology
- 25 shared
Rashmi Arora
Industrial Research Institute
Education
- 2004
Ph.D Biochemistry, Department of Biochemistry
Aligarh Muslim University Faculty of Life Sciences
- 1999
M.Sc Biochemistry, Department of Bioschemistry
Aligarh Muslim University Faculty of Life Sciences
- 1997
B.Sc (Hons) Biochemistry, Department of Biochemistry
Aligarh Muslim University Faculty of Life Sciences
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Pawan Gupta
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup